| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.043 | 0.5 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | 0.038 | 0.5 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.028 | 0.5 |
| mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | -0.029 | 0.5 |
| mRNA | Obatoclax Mesylate | GDSC1000 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | ZSTK474 | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Vorinostat | FIMM | pan-cancer | AAC | 0.12 | 0.5 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |